Ehrnebo M - Search Results

1

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.

Bergquist F, Ehrnebo M, Nyholm D, Johansson A, Lundin F, Odin P, Svenningsson P, Hansson F, Bring L, Eriksson E, Dizdar N. Bergquist F, et al. Among authors: ehrnebo m. Neurology. 2022 Sep 5;99(10):e965-e976. doi: 10.1212/WNL.0000000000200804. Neurology. 2022. PMID: 35705502 Free PMC article. Clinical Trial.

2

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers.

Nyholm D, Lewander T, Gomes-Trolin C, Bäckström T, Panagiotidis G, Ehrnebo M, Nyström C, Aquilonius SM. Nyholm D, et al. Among authors: ehrnebo m. Clin Neuropharmacol. 2012 May-Jun;35(3):111-7. doi: 10.1097/WNF.0b013e31825645d1. Clin Neuropharmacol. 2012. PMID: 22549097 Clinical Trial.

3

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.

Nyholm D, Ehrnebo M, Lewander T, Trolin CG, Bäckström T, Panagiotidis G, Spira J, Nyström C, Aquilonius SM. Nyholm D, et al. Among authors: ehrnebo m. Acta Neurol Scand. 2013 Feb;127(2):124-32. doi: 10.1111/j.1600-0404.2012.01700.x. Epub 2012 Jul 4. Acta Neurol Scand. 2013. PMID: 22762460 Clinical Trial.

4

Pharmacokinetic and metabolic studies of high-dose busulphan in adults.

Hassan M, Oberg G, Ehrsson H, Ehrnebo M, Wallin I, Smedmyr B, Tötterman T, Eksborg S, Simonsson B. Hassan M, et al. Among authors: ehrnebo m. Eur J Clin Pharmacol. 1989;36(5):525-30. doi: 10.1007/BF00558081. Eur J Clin Pharmacol. 1989. PMID: 2753072

5

A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations.

Boréus LO, Nergårdh A, Ehrnebo M, Theorell K. Boréus LO, et al. Among authors: ehrnebo m. J Neurol. 1980;223(4):241-9. doi: 10.1007/BF00313338. J Neurol. 1980. PMID: 6157786

6

Busulfan kinetics.

Ehrsson H, Hassan M, Ehrnebo M, Beran M. Ehrsson H, et al. Among authors: ehrnebo m. Clin Pharmacol Ther. 1983 Jul;34(1):86-9. doi: 10.1038/clpt.1983.134. Clin Pharmacol Ther. 1983. PMID: 6574831

7

Effect of food on kinetics of 8-methoxsalen.

Ehrsson H, Nilsson SO, Ehrnebo M, Wallin I, Wennersten G. Ehrsson H, et al. Among authors: ehrnebo m. Clin Pharmacol Ther. 1979 Feb;25(2):167-71. doi: 10.1002/cpt1979252167. Clin Pharmacol Ther. 1979. PMID: 759069

8

Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis.

Swanbeck G, Ehrsson H, Ehrnebo M, Wallin I, Jonsson L. Swanbeck G, et al. Among authors: ehrnebo m. Clin Pharmacol Ther. 1979 Apr;25(4):478-80. Clin Pharmacol Ther. 1979. PMID: 428192

9

Degradation of chlorambucil in aqueous solution--influences of human albumin binding.

Ehrsson H, Lönroth U, Wallin I, Ehrnebo M, Nilsson SO. Ehrsson H, et al. Among authors: ehrnebo m. J Pharm Pharmacol. 1981 May;33(5):313-5. doi: 10.1111/j.2042-7158.1981.tb13787.x. J Pharm Pharmacol. 1981. PMID: 6116780 No abstract available.

10

Pharmacokinetics and distribution of flucloxacillin in pacemaker patients.

Anderson P, Bluhm G, Ehrnebo M, Herngren L, Jacobson B. Anderson P, et al. Among authors: ehrnebo m. Eur J Clin Pharmacol. 1985;27(6):713-9. doi: 10.1007/BF00547055. Eur J Clin Pharmacol. 1985. PMID: 3987776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page